NeonMind Reports Business Highlights on Partnership Activities, Clinical Pipeline and Corporate Developments
Almost 40% of adults are overweight and obesity rates have tripled since the 70s. Luckily, both micro and macro doses of psilocybin may be able to combat this.
How? Psilocybin is structurally similar to serotonin, which is known to suppress the appetite.
NeonMind (NEON) found that when rats had unlimited access to food, those on both high and low doses of psilocybin gained 30% less weight than a control group.
The company is preparing for a clinical trial to see if a high dose of psilocybin combined with behavioral therapy and lifestyle intervention can aid in weight management. NeonMind is also developing a psilocybin microdose to control hunger.
Learn more about psychedelics and microdosing with Chloe Deutscher on TikTok!